Weihua Lan

1.2k total citations
48 papers, 915 citations indexed

About

Weihua Lan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Weihua Lan has authored 48 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Weihua Lan's work include Cancer, Hypoxia, and Metabolism (8 papers), Prostate Cancer Treatment and Research (7 papers) and Renal cell carcinoma treatment (6 papers). Weihua Lan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Prostate Cancer Treatment and Research (7 papers) and Renal cell carcinoma treatment (6 papers). Weihua Lan collaborates with scholars based in China, United States and United Kingdom. Weihua Lan's co-authors include Jun Jiang, Ping Xiao, Qiuli Liu, Dianzheng Zhang, Dali Tong, Gaolei Liu, Luofu Wang, Jing Xu, Hualiang Xiao and Jian Pang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Science Advances.

In The Last Decade

Weihua Lan

43 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weihua Lan China	16	411	230	200	199	94	48	915
Xiaozhong Chen China	23	347 0.8×	312 1.4×	131 0.7×	294 1.5×	222 2.4×	117	1.4k
Luyan Shen China	21	616 1.5×	259 1.1×	261 1.3×	122 0.6×	111 1.2×	70	1.2k
Zhangfu Yang China	18	288 0.7×	139 0.6×	232 1.2×	97 0.5×	80 0.9×	44	795
Yiwei Jiang China	17	211 0.5×	331 1.4×	230 1.1×	104 0.5×	49 0.5×	80	874
Yanna Zhang China	22	437 1.1×	262 1.1×	305 1.5×	123 0.6×	91 1.0×	71	1.0k
Dae Hoon Kim South Korea	16	746 1.8×	301 1.3×	94 0.5×	155 0.8×	153 1.6×	62	1.3k
Weipeng Zhao China	16	501 1.2×	379 1.6×	205 1.0×	226 1.1×	70 0.7×	67	1.1k
Jianzhou Liu China	17	291 0.7×	117 0.5×	190 0.9×	104 0.5×	122 1.3×	65	929
Hongxue Meng China	20	479 1.2×	321 1.4×	254 1.3×	262 1.3×	93 1.0×	102	1.4k

Countries citing papers authored by Weihua Lan

Since Specialization

Citations

This map shows the geographic impact of Weihua Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Lan more than expected).

Fields of papers citing papers by Weihua Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihua Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Lan. The network helps show where Weihua Lan may publish in the future.

Co-authorship network of co-authors of Weihua Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Lan. A scholar is included among the top collaborators of Weihua Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Lan. Weihua Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lv, Yang, Mingfeng Zhao, Xinyi Liu, et al.. (2025). Clinical features and therapeutic experiences of renal cancer related to Xp11.2 translocation/TFE3 gene fusion: A case series of 18 patients. Pathology - Research and Practice. 271. 156052–156052.

Tang, Peng, Jian Chen, Jing Xu, et al.. (2025). Trends and hotspots in targeted therapy resistance research for renal cell carcinoma: a bibliometric and visualization analysis. Discover Oncology. 16(1). 1055–1055.

Wang, Ze, Peng Song, Jian Chen, et al.. (2024). Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1–SNAI1 axis. The Journal of Pathology. 264(1). 68–79. 2 indexed citations

Wang, Shuo, Weihua Lan, Yapeng Wang, et al.. (2024). Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Medicine. 13(21). e70398–e70398. 1 indexed citations

Wang, Bo, et al.. (2024). The Clinical Investigation on Varicocele and Sperm Quality in the Tibet an Plateau of China: A Prospectively Planned Retrospective Cohort Study. American Journal of Men s Health. 18(2). 1044150756–1044150756.

Liu, Gaolei, Hao Luo, Dandan Liang, et al.. (2024). Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer. Recent Patents on Anti-Cancer Drug Discovery. 20(2). 185–199. 1 indexed citations

Chen, Jian, Qiming Chen, Ze Wang, et al.. (2024). Establishing a model predicting Gleason grade group upgrading in prostate cancer. Translational Andrology and Urology. 13(8). 1378–1387. 1 indexed citations

Wang, Yapeng, Jing Xu, Yan Qian, et al.. (2024). Characterization of T cell receptor repertoire in penile cancer. Cancer Immunology Immunotherapy. 73(2). 24–24. 4 indexed citations

Lan, Weihua, Luofu Wang, Dianzheng Zhang, et al.. (2023). PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. Science Advances. 9(31). eadf3566–eadf3566. 17 indexed citations

10.

Tang, Peng, Jun Zhang, Peng Song, et al.. (2023). Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations. BMC Endocrine Disorders. 23(1). 77–77. 4 indexed citations

11.

Tang, Peng, Tang Tang, Yapeng Wang, et al.. (2022). Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 26(1). 180–187. 9 indexed citations

12.

Luo, Hao, Gaolei Liu, Dan Jian, et al.. (2022). Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. Journal of Immunology Research. 2022. 1–21. 1 indexed citations

13.

Yu, Zhiping, Dan Xu, Yanli Guo, et al.. (2020). Anti-G250 nanobody-functionalized nanobubbles targeting renal cell carcinoma cells for ultrasound molecular imaging. Nanotechnology. 31(20). 205101–205101. 29 indexed citations

14.

Tang, Tang, Jian Pang, Jing Xu, et al.. (2020). LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT. Frontiers in Oncology. 10. 1234–1234. 34 indexed citations

15.

Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2018). Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration. Clinical Cancer Research. 24(22). 5622–5634. 86 indexed citations

16.

Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families. Medicine. 96(3). e5967–e5967. 10 indexed citations

17.

Tong, Dali, Yanli Guo, Weihua Lan, et al.. (2016). The HIF/PHF8/AR axis promotes prostate cancer progression. Oncogenesis. 5(12). e283–e283. 49 indexed citations

18.

Tong, Dali, Qiuli Liu, Gaolei Liu, et al.. (2016). Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. Cancer Letters. 389. 23–32. 106 indexed citations

19.

Lan, Weihua, et al.. (2011). Microstructure and magnetic behaviors of FeSi‐ZrO ₂ nanocomposite films. Rare Metals. 30(S1). 533–537. 1 indexed citations

20.

Zhang, Yao, Gang Wu, Hua Yang, et al.. (2011). Transumbilical Laparoendoscopic Single-Site Renal Pedicle Lymphatic Disconnection for Refractory Chyluria. Journal of Endourology. 25(8). 1337–1341. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact